The mature SM marker CNN1 was consistently decreased (Fig. 1A-C; Fig. S1) as previously reported (Tuxhorn et al., 2002), and the area of ACTA2 expression seemed decreased in most, but not all, PCa samples (Fig. 1D-F; Fig. S2). The gene discussed is ACTA2; the disease is posterior cortical atrophy.